Trials / Unknown
UnknownNCT00458666
Coagulation Parameters During Pregnancy in Amniotic Fluid
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 170 (planned)
- Sponsor
- Rambam Health Care Campus · Academic / Other
- Sex
- Female
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
Amniotic fluid embolism is a rare devastating thromboembolic event, which is probably caused by the entrance of amniotic fluid (AF) to the maternal circulation. While AF contains coagulation activators, their role during pregnancy has not been elucidated. The current study aimed to evaluate coagulation parameters in AF during human pregnancy.
Detailed description
Amniotic fluid embolism is a rare devastating thromboembolic event, which is probably caused by the entrance of amniotic fluid (AF) to the maternal circulation. While AF contains coagulation activators, their role during pregnancy has not been elucidated. The current study aimed to evaluate coagulation parameters in AF during human pregnancy.
Conditions
Timeline
- Start date
- 2006-06-01
- First posted
- 2007-04-11
- Last updated
- 2007-04-11
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT00458666. Inclusion in this directory is not an endorsement.